Charles Schwab Investment Management Inc. Grows Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Charles Schwab Investment Management Inc. raised its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 43.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 938,187 shares of the company's stock after purchasing an additional 286,380 shares during the period. Charles Schwab Investment Management Inc. owned about 0.36% of Ryan Specialty worth $62,286,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. GAMMA Investing LLC increased its position in Ryan Specialty by 96.4% during the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after purchasing an additional 297 shares in the last quarter. Anderson Hoagland & Co. grew its position in shares of Ryan Specialty by 1.2% during the 2nd quarter. Anderson Hoagland & Co. now owns 51,615 shares of the company's stock valued at $2,909,000 after buying an additional 624 shares during the last quarter. Renaissance Capital LLC raised its position in shares of Ryan Specialty by 45.1% during the 2nd quarter. Renaissance Capital LLC now owns 91,929 shares of the company's stock worth $5,324,000 after purchasing an additional 28,565 shares during the period. SG Americas Securities LLC lifted its holdings in shares of Ryan Specialty by 327.9% in the 2nd quarter. SG Americas Securities LLC now owns 19,481 shares of the company's stock worth $1,128,000 after purchasing an additional 14,928 shares during the last quarter. Finally, Mechanics Bank Trust Department bought a new stake in Ryan Specialty in the 2nd quarter valued at about $376,000. Hedge funds and other institutional investors own 84.82% of the company's stock.

Insider Buying and Selling

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the firm's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the transaction, the executive vice president now owns 12,386 shares in the company, valued at $884,236.54. This trade represents a 54.42 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company's stock, valued at $5,539,201.12. This represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.

Ryan Specialty Price Performance

Shares of RYAN stock traded up $0.31 on Friday, hitting $75.40. 433,476 shares of the company's stock were exchanged, compared to its average volume of 869,154. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market cap of $19.74 billion, a P/E ratio of 97.92, a price-to-earnings-growth ratio of 1.70 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.97. The company has a 50 day moving average of $69.99 and a 200 day moving average of $63.12.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business had revenue of $604.69 million for the quarter, compared to analysts' expectations of $602.04 million. During the same period in the prior year, the business posted $0.32 earnings per share. The firm's revenue was up 20.5% on a year-over-year basis. On average, equities research analysts predict that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current year.

Ryan Specialty Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.58%. Ryan Specialty's payout ratio is presently 57.14%.

Analyst Ratings Changes

RYAN has been the topic of a number of recent analyst reports. BMO Capital Markets upgraded shares of Ryan Specialty from a "market perform" rating to an "outperform" rating and boosted their price target for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. The Goldman Sachs Group increased their price objective on Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 9th. Bank of America boosted their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Wells Fargo & Company lifted their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a research note on Thursday, October 10th. Finally, Barclays upped their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a research report on Thursday, November 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $71.67.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.